Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Céline Colacios

Université Paul Sabatier

France

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

50%

Pharmacotherapy

20%

Tumor Suppression

30%

Immunomodulation

20%

Graft-versus-host Disease

20%

Targeted Therapy

20%

Immunotherapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles6

TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study

Article Link

Year:

2025

Combining TNF blockade with immune checkpoint inhibitors in patients with cancer.

Article Link

Year:

2021

Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer.

Article Link

Year:

2021

Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.

Article Link

Year:

2021

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

Article Link

Year:

2020

Combining nivolumab and ipilimumab with infliximab or certolizumab in patients with advanced melanoma: first results of a phase 1b clinical trial.

Article Link

Year:

2020

Collaborators6

Thomas FARGE

Associate Professor - MCF

Université Toulouse III - Paul Sabatier

FRANCE

Anne Montfort

Institut Universitaire du Cancer de Toulouse

FRANCE

Bruno Ségui

Professor

Université Paul Sabatier

FRANCE

Odile Schiltz

FRANCE

Sophie Tartare‐Deckert

FRANCE

Anne Gonzalez de Peredo

FRANCE

How do I reach out?

Meet Kite AI